Discern and NPC publish key outcomes from oncology value-based care webinar

April 2019

On March 21, the National Pharmaceutical Council (NPC) and Discern Health published the key takeaways from a “Policy Solutions for Improving Patient-Reported Measures in Oncology Value-Based Payment Programs” webinar discussion. The summary can be found here: https://www.npcnow.org/blog/loud-and-clear-key-takeaways-webinar-amplifying-patient-voice-quality-measurement.   Theresa Schmidt (tschmidt@discernhealth.com), a Director at Discern, led our team’s effort and would be excited to talk…

Read more

Discern Adds Senior Staff

April 2019

Discern has added several key members to its team to expand our staff’s capacity and the areas in which we can help clients succeed in the value-based environment. Manasi Tirodkar, PhD, joined Discern as a Director in March. She has a strong background in health services research, quality measurement, and practice transformation in primary and…

Read more

Kaitlyn Whiton promoted to Sr. Project Manager

April 2019

We are proud to announce that Kaitlyn Whiton has been promoted to Senior Project Manager. In her time at Discern, Kaitlyn has successfully managed multiple projects and played a major role in building Discern’s data analytics capabilities. She has helped conceptualize and lead projects while being an effective supervisor and mentor to project analysts. Client…

Read more

Discern Opens Washington, D.C. Office

February 2019

Discern Health has opened an office in Washington, D.C. Located one block from Union Station at 10 G Street, NE, the new office strengthens Discern’s proximity to health policy leaders and clients. The D.C. office has room for seven staff members and will complement Discern’s main office location in Baltimore. “We’re excited about this important…

Read more

National Pharmaceutical Council and Discern Health Outline Strategies for Improving Patient-Reported Measures in Oncology

February 2019

(Washington, DC, February 21, 2019) – The National Pharmaceutical Council (NPC) and Discern Health today released a study that analyzes the landscape of available patient-reported measures (PRMs) and patient-reported performance measures (PR-PMs) in oncology and offers recommendations for filling gaps in measures and removing barriers to measure implementation. The study, “Improving Patient-reported Measures in Oncology,”…

Read more

Discern Endorses New National Guidelines That Call For Improved Access To Palliative Care

November 2018

Palliative care can help people living with serious illness and their families deal with the physical symptoms and psychosocial burdens of illness and treatment. Although palliative care can be delivered concurrently with disease-focused treatment to improve quality of life, many Americans do not have access to needed services. To improve access to palliative care, new…

Read more

Discern Health Is Seeking New Team Members

November 2018

Discern Health is looking to expand our capacity to provide strategic direction and solutions to government, health provider systems, health insurers, and life sciences companies. We’re seeking staff at all levels to join our client service teams in providing insightful qualitative research, quantitative analysis and evidence-based recommendations for quality strategies, performance measurement, and value-based care….

Read more

Discern Plays Leadership Role In Primary Care Transformation

November 2018

Revitalizing primary care is crucial to achieving a high-quality, affordable, accessible, and efficient health care system. While the patient-centered medical home model has helped to transform the organization and delivery of primary care, new payment models are also required to support practices as they journey from fee-for-service to value-based health care. To support the increased…

Read more

Discern VP Quoted In The Minnesota Star Tribune

November 2018

Russ Montgomery was recently called on by the Minnesota Star Tribune to comment about the long-term value and costs associated with new diabetes pumps and monitors. Russ has worked on several projects related to the value of medical devices in diabetes and other chronic conditions, and his inclusion in this article is clear recognition of…

Read more

Discern Partner Tom Valuck To Lead Expert Panel At MedTech Conference

September 2018

At the MedTech Conference in Philadelphia, Tom Valuck, M.D., J.D., and expert panelists Keely Scamperle (W.L. Gore) and Peter Kelly (Abbott Laboratories) will lead an interactive discussion on “Quality Measurement Implications for Medical Technology in the Value-Based Environment.” Tom will ask Keely and Peter questions about hot topic issues they have faced as quality leaders…

Read more